Comparable stake leader
BlackRock, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001217234.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
05 Aug 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
9%
from 13D/G
|
$137,219,211
4,814,709 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
4.8%
|
$70,387,142
2,468,858 shares
|
-$7,666,168 | 30 Jun 2026 |
| ARK Investment Management LLC |
13F
13D/G
Company
|
4.5%
from 13D/G
|
$55,675,622
1,953,531 shares
|
— | 30 Jun 2026 |
| GAGNON SECURITIES LLC |
13D/G
13F
Neil Gagnon · Company
|
4.4%
|
$65,386,659
2,293,464 shares
|
-$21,709,852 | 31 Jul 2026 |
| BAMCO INC /NY/ |
13D/G
13F
Baron Capital Group, Inc. · Company
|
3.8%
|
$55,233,164
1,937,326 shares
|
-$34,721,018 | 30 Jun 2026 |
| Abhishek Jain |
3/4/5
Chief Financial Officer
|
0.62%
|
$3,907,039
319,725 shares
|
— | 01 Aug 2025 |
| Keith Kennedy |
3/4/5
CFO & COO
|
0.43%
|
$3,817,880
219,924 shares
|
— | 01 Jul 2026 |
| Jessica Meng |
3/4/5
Chief Commercial Officer
|
0.33%
|
$2,921,462
168,287 shares
|
— | 01 Jul 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$13,308,479.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 326,786 | $0 | $11,922,227 | -$11,922,227 |
| 3-6 | 0 | 23,540 | $0 | $487,412 | -$487,412 |
| 6-9 | 0 | 41,370 | $0 | $857,117 | -$857,117 |
| 9-12 | 0 | 2,688 | $0 | $41,723 | -$41,723 |
Reporting owners
Showing 1-20 of 23 reporting-owner rows connected to CareDx, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John Walter Hanna Jr. | President and CEO, Director | $25,493,424 | -$7,540,919 | -23% | Filing P/S | 16 Jul 2026 |
| Alexander L. Johnson | President of Patient and Testing Services | $9,284,746 | Filing P/S | 20 Aug 2024 | ||
| George Bickerstaff | Director | $6,205,013 | -$925,700 | -13% | Filing P/S | 05 Aug 2026 |
| Abraham Ronai | Officer | $6,160,873 | Mixed | 20 Sep 2023 | ||
| Peter Maag | Director | $5,745,904 | Mixed | 07 Jul 2025 | ||
| Reginald Seeto | President and Chief Executive Officer, Director | $5,721,218 | Mixed | 02 Oct 2023 | ||
| Michael Goldberg | Director | $5,500,054 | -$2,103,497 | -28% | Mixed | 04 Aug 2026 |
| Jeffrey Adam Novack | Secretary and General Counsel | $4,959,006 | -$452,744 | -8.4% | Filing P/S | 05 Aug 2026 |
| Abhishek Jain | Chief Financial Officer | $3,907,039 | Mixed | 01 Aug 2025 | ||
| Keith Kennedy | Cfo & Coo | $3,817,880 | Mixed | 01 Jul 2026 | ||
| Fred E. Cohen | Director | $2,950,014 | Mixed | 12 Jun 2026 | ||
| Jessica Meng | Chief Commercial Officer | $2,921,462 | Mixed | 01 Jul 2026 | ||
| Christine Cournoyer | Director | $2,100,137 | -$750,973 | -26% | Mixed | 04 Aug 2026 |
| Sasha King | Chief Marketing Officer | $1,697,173 | Mixed | 09 Aug 2022 | ||
| Nathan Smith | Chief Financial Officer | $1,613,506 | Mixed | 02 Feb 2026 | ||
| Hannah Valantine | Director | $1,340,873 | -$1,319,971 | -50% | Filing P/S | 16 Jul 2026 |
| William A. Hagstrom | Director | $1,158,857 | Mixed | 11 Jun 2025 | ||
| Arthur A. Torres | Director | $853,685 | -$214,676 | -20% | Mixed | 14 May 2026 |
| Richard Bryan Riggsbee | Director | $767,029 | Mixed | 12 Jun 2026 | ||
| Ralph Snyderman | Director | $694,633 | Mixed | 04 Oct 2022 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -2.47% | $124,349 | $46.26 | -2,688 | 106,075 | 05 Aug 2026 | Direct |
| George Bickerstaff | CDNA | Common Stock | Sale | -13% | $925,700 | $46.28 | -20,000 | 134,061 | 05 Aug 2026 | Direct |
| Michael Goldberg | CDNA | Common Stock | Sale | -42% | $2,103,497 | $47.06 | -44,700 | 61,738 | 04 Aug 2026 | Direct |
| Christine Cournoyer | CDNA | Common Stock | Sale | -27.1% | $750,973 | $46.94 | -16,000 | 42,943 | 04 Aug 2026 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -2.57% | -2,872 | 108,763 | 01 Aug 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -15.3% | $4,458,637 | $37.79 | -118,000 | 653,448 | 16 Jul 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Options Exercise | 18.1% | 118,000 | 771,448 | 16 Jul 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Employee Stock Option (Right to Buy) | Options Exercise | -18.7% | -118,000 | 512,706 | 16 Jul 2026 | Direct | ||
| Hannah Valantine | CDNA | Common Stock | Sale | -44% | $1,040,243 | $36.15 | -28,779 | 36,686 | 16 Jul 2026 | Direct |
| Hannah Valantine | CDNA | Common Stock | Options Exercise | 78.4% | 28,779 | 65,465 | 16 Jul 2026 | Direct | ||
| Hannah Valantine | CDNA | Stock Option (Right to Buy) | Options Exercise | -100% | -28,779 | 0 | 16 Jul 2026 | Direct | ||
| Michael Goldberg | CDNA | Common Stock | Award | 1.67% | 1,746 | 106,438 | 02 Jul 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Tax liability | -1.29% | -8,511 | 653,448 | 01 Jul 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -0.89% | -997 | 111,635 | 01 Jul 2026 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Tax liability | -1.41% | -2,411 | 168,287 | 01 Jul 2026 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Tax liability | -1.31% | -2,930 | 219,924 | 01 Jul 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -5.68% | $1,166,836 | $29.24 | -39,900 | 661,959 | 29 Jun 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Options Exercise | 6.03% | 39,900 | 701,859 | 29 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Employee Stock Option (right to buy) | Options Exercise | -5.95% | -39,900 | 630,706 | 29 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -0.02% | $2,900 | $29.00 | -100 | 661,959 | 26 Jun 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Options Exercise | 0.02% | 100 | 662,059 | 26 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Employee Stock Option (right to buy) | Options Exercise | -0.01% | -100 | 670,606 | 26 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Options Exercise | 2.43% | 15,676 | 661,959 | 15 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Employee Stock Option (right to buy) | Options Exercise | -2.28% | -15,676 | 670,706 | 15 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -2.72% | $424,877 | $24.03 | -17,683 | 631,959 | 15 Jun 2026 | Direct |
| Hannah Valantine | CDNA | Common Stock | Sale | -24.8% | $279,728 | $23.11 | -12,103 | 36,686 | 15 Jun 2026 | Direct |
| Hannah Valantine | CDNA | Common Stock | Award | 25.1% | 9,795 | 48,789 | 12 Jun 2026 | Direct | ||
| Christine Cournoyer | CDNA | Common Stock | Award | 19.9% | 9,795 | 58,943 | 12 Jun 2026 | Direct | ||
| Richard Bryan Riggsbee | CDNA | Common Stock | Award | 33.2% | 9,795 | 39,312 | 12 Jun 2026 | Direct | ||
| Fred E. Cohen | CDNA | Common Stock | Award | 6.31% | 9,795 | 165,060 | 12 Jun 2026 | Direct | ||
| Suresh Gunasekaran | CDNA | Common Stock | Award | 35.7% | 9,795 | 37,248 | 12 Jun 2026 | Direct | ||
| George Bickerstaff | CDNA | Common Stock | Award | 6.79% | 9,795 | 154,061 | 12 Jun 2026 | Direct | ||
| Michael Goldberg | CDNA | Common Stock | Award | 5.27% | 9,795 | 195,737 | 12 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Options Exercise | 2.15% | 13,618 | 646,283 | 11 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Employee Stock Option (right to buy) | Options Exercise | -1.95% | -13,618 | 686,382 | 11 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -3.28% | $528,443 | $24.02 | -21,998 | 649,642 | 11 Jun 2026 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -1.13% | -1,292 | 112,632 | 06 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Options Exercise | 0.11% | 706 | 632,665 | 04 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Employee Stock Option (right to buy) | Options Exercise | -0.1% | -706 | 700,000 | 04 Jun 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -0.71% | $116,045 | $24.00 | -4,835 | 671,640 | 04 Jun 2026 | Direct |
| Arthur A. Torres | CDNA | Common Stock | Sale | -14.4% | $128,978 | $19.89 | -6,484 | 38,665 | 15 May 2026 | Direct |
| Arthur A. Torres | CDNA | Common Stock | Sale | -8.3% | $85,698 | $20.97 | -4,086 | 45,149 | 14 May 2026 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -2.31% | $55,581 | $20.68 | -2,688 | 113,924 | 05 May 2026 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -2.4% | -2,873 | 116,612 | 01 May 2026 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Award | 12.2% | 24,134 | 221,548 | 20 Apr 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -1.5% | $217,156 | $21.12 | -10,282 | 676,475 | 16 Apr 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Tax liability | -8.29% | -62,049 | 686,757 | 15 Apr 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -1.56% | -1,892 | 119,485 | 06 Apr 2026 | Direct | ||
| Michael Goldberg | CDNA | Common Stock | Award | 1.08% | 1,981 | 185,942 | 02 Apr 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Tax liability | -4.47% | -35,037 | 748,806 | 01 Apr 2026 | Direct |